Linear porokeratosis: A case report and review of the literature

Cutis

Volumn 81, Issue 6, 2008, Pages 479-483

  Lorenz, Giovanni E ^a   Ritter, Steven E ^b,c  

^a Touro University California   (United States)

^b Wright Patterson Medical Center   (United States)

^c USAF Medical Center Keesler   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; HUMAN; MALE; POROKERATOSIS; REVIEW;

ADULT; HUMANS; MALE; POROKERATOSIS;

EID: 51049117229     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Mibelli V. Contributo allo studio della ipercheratosi dei canali sudoriferi. G Ital Mal Veneree Pelle. 1893;28: 313-355.
2. Respighi E. Di una ipercheratosi non ancora descritta. G Ital Mal Veneree Pelle. 1893;28:356-386.
3. Wolff-Schreiner EC. Porokeratosis. In: Fitzpatrick T, Eisen A, Wolff K, et al, eds. Dermatology in General Medicine. Vol 1. 5th ed. New York, NY: McGraw-Hill; 1999:624-630.
4. Ousager LB, Brandrup F, Brasch-Andersen C, et al. Skin manifestations in a case of trisomy 16 mosaicism. Br J Dermatol. 2006;154:172-176.
5. Happle R. Dohi Memorial Lecture, new aspects of cutaneous mosaicism. J Dermatol. 2002;29:681-692.
6. Dover JS, Phillips TJ, Burns DA, et al. Disseminated superficial actinic porokeratosis, coexistence with other porokeratotic variants. Arch Dermatol. 1986;122:887-889.
7. Kaur S, Thami GP, Mohan H, et al. Co-existence of variants of porokeratosis: a case report and a review of the literature. J Dermatol. 2002;29:305-309.
8. Xia K, Deng H, Xia JH, et al. A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1-26.1. Br J Dermatol. 2002;147: 650-654.
9. Wu LQ, Yang YF, Zheng D, et al. Confirmation and refinement of a genetic locus for disseminated superficial actinic porokeratosis (DSAPl) at 12q23.2-24.1. Br J Dermatol. 2004;150:999-1004.
10. Wei SC, Yang S, Li M, et al. Identification of a locus for porokeratosis palmaris et, plantaris disseminata to a 6.9-cM region at chromosome 12q24.1 -24.2. Br J Dermatol. 2003;149:261-267.
11. Nova MP, Goldberg LJ, Mattison T, et al. Porokeratosis arising in a burn scar. J Am Acad Dermatol. 1991;25: 354-356.
12. Katugampola RP, Finlay AY. Fake sun tan diagnosis of porokeratosis. J Eur Acad Dermatol Venereol. 2006;20: 224-226.
13. Fleischer AB Jr, Donahue MJ, Feldman SR. Tanning salon porokeratosis. J Am Acad Dermatol. 1993;29(5, pt 1): 787-788.
14. Romani J, Pujol RM, Casanova JM, et al. Disseminated superficial porokeratosis developing after electron-beam total skin irradiation for mycosis fungoides. Clin Exp Dermatol. 1996;21:310-312.
15. Jang YH, Chun SJ, Kang WH, et al. Eruptive disseminated superficial actinic porokeratosis in an immunocompetent host: is this associated with herpes simplex virus or bacterial infection? J Am Acad Dermatol. 2004;51:1018-1019.
16. Webster GF. Are porokeratoses an infection [letter]? Arch Dermatol. 2001;137:665.
17. Mizukawa Y, Shiohara T. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C virus infection provide a link between porokeratosis and immunosuppression? Br J Dermatol. 1999;141:163-164.
18. Kono T, Kobayashi H, lshii M, et al. Synchronous development of disseminated superficial porokeratosis and hepatitis C virus-related hepatocellular carcinoma. J Am Acad Dermatol. 2000;43:966-968.
19. Silver SG, Crawford RI. Fatal squamous cell carcinoma arising from transplant-associated porokeratosis. J Am Acad Dermatol. 2003;49:931-933.
20. Knoell KA, Patterson JW, Wilson BB. Sudden onset of disseminated porokeratosis of Mibelli in a renal transplant patient. J Am Acad Dermatol. 1999;41:830-832.
21. Kanitakis J, Euvrard S, Faure M, et al. Porokeratosis and immunosuppression. Eur J Dermatol. 1998;8:459-465.
22. Herranz P, Pizarro A, De Lucas R, et al. High incidence of porokeratosis in renal transplant recipients. Br J Dermatol. 1997;136:176-179.
23. Ponticelli C, Bencini PL. Disseminated porokeratosis in immunosuppressed patients. Nephrol Dial Transplant. 1996;11:2353-2354.
24. Fields LL, White CR Jr, Maziarz RT. Rapid development of disseminated superficial porokeratosis after transplant induction therapy. Bone Marrow Transplant. 1995;15: 993-995.
25. Reed RJ, Leone P. Porokeratosis - a mutant clonal keratosis of the epidermis. Arch Dermatol. 1970;101: 340-347.
26. Jurecka W, Neumann RA, Knobler RM. Porokeratoses: immunohistochemical, light and electron microscopic evaluation. J Am Acad Dermatol. 1991;24: 96-101.
27. Rahbari H, Cordero AA, Mehregan AH. Punctate porokeratosis, a clinical variant of porokeratosis of Mibelli. J Cutan Pathol. 1977;4:338-341.
28. Feldman SR, Woosley JT. Use of Sedi-Stain for the diagnosis of elastosis perforans serpiginosa. J Am Acad Dermatol. 1989;20:1137-1138.
29. Eczema and hand dermatitis. In: Habif TP, ed. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, PA: Mosby; 2004:41-80.
30. 2 laser vaporization versus surgical excision with split-thickness skin graft, a comparison. J Dermatol Surg Oncol. 1993;19:199-203.
31. Barnett JH. Linear porokeratosis: treatment with the carbon dioxide laser. J Am Acad Dermatol. 1986; 14 (5, pt2):902-904.
32. Hubler WR Jr, Michaelson JD, Knox JM. Linear porokeratosis. Cutis. 1974;14:61-64.
33. Harrison S, Sinclair R. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream. Australas J Dermatol. 2003;44:281-283.
34. Pehamberger H, Konrad K. Treatment with an oral aromatic retinoid in linear porokeratosis. Dermatologica. 1980;160:270-274.
35. Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dermatol. 1995;131:496-497.
36. Curnow P, Foley P, Baker C. Multiple squamous cell carcinomas complicating linear porokeratosis. Australes J Dermatol. 2003;44:136-139.
37. Sasaki S, Urano Y, Nakagawa K, et al. Linear porokeratosis with multiple squamous cell carcinomas: study of p53 expression in porokeratosis and squamous cell carcinoma. Br J Dermatol. 1996;134:1151-1153.
38. Lucker GP, Steijlen PM. The coexistence of linear and giant porokeratosis associated with Bowen's disease. Dermatology. 1994;189:78-80.
39. Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol. 1994;130:187-190.
40. McNutt NS, Saenz-Santamaria C, Volkenandt M, et al. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol. 1994;130:225-232.
41. Urano Y, Sasaki S, Ninomiya Y, et al. Immunohistochemical detection of p53 tumor suppressor protein in porokeratosis. J Dermatol. 1996;23:365-368.
42. Karthikeyan K, Thappa DM, Udayashankar C. Porokeratosis of Mibelli with nail dystrophy. J Dermatol. 2003;30: 420-422.
43. Chen HH, Liao YH. Onychodystrophy in congenital linear porokeratosis. Br J Dermatol. 2002;147:1272-1273.
44. Itin PH. Porokeratosis plantaris, palmaris et disseminata with multiple filiform hyperkeratoses and nail dystrophy [in German]. Hautarzt. 1995;46:869-872.
45. Tseng SS, Levit EK, Ilarda I, et al. Linear porokeratosis with underlying bony abnormalities. Cutis. 2002;69:309-312.